Viji Shridhar

6PUBLICATIONS
7CO-AUTHORS
Proteins and peptidesPredictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 07, 2023
PG545 sensitizes ovarian cancer cells to PARP inhibitors through modulation of RAD51-DEK interaction.

Upasana Ray, Prabhu Thirusangu, Ling Jin

|Nov 28, 2022
Correction to: PFKFB3 regulates cancer stemness through the hippo pathway in small cell lung carcinoma.

Prabhu Thirusangu, Upasana Ray, Sayantani Sarkar Bhattacharya

|Jul 08, 2022
PFKFB3 regulates cancer stemness through the hippo pathway in small cell lung carcinoma.

Prabhu Thirusangu, Upasana Ray, Sayantani Sarkar Bhattacharya

|Jul 06, 2022
PFKFB3 works on the FAK-STAT3-SOX2 axis to regulate the stemness in MPM.

Sayantani Sarkar Bhattacharya, Prabhu Thirusangu, Ling Jin

|Mar 09, 2022
Exploiting LRRC15 as a Novel Therapeutic Target in Cancer.

Upasana Ray, Christopher L Pathoulas, Prabhu Thirusangu

|Jan 09, 2021
Inhibition of PFKFB3 induces cell death and synergistically enhances chemosensitivity in endometrial cancer.

Yinan Xiao, Ling Jin, Chaolin Deng

Pageof 1

Frequent Collaborators

3 joint publications

Nagarajan Kannan

3 joint publications

Sayantani Sarkar Bhattacharya

1 joint publications

Yinan Xiao

1 joint publications

Julian R Molina